XBI ETF holdings Page 2
Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
| Snapshot field | Reported value |
|---|
| Fund | State Street(R) SPDR(R) S&P(R) Biotech ETF |
|---|
| Report date | 2026-03-31 |
|---|
| Reported holdings | 158 |
|---|
| SEC series ID | S000010018 |
|---|
Positions 101–158 of 158
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| TYRA | Tyra Biosciences Inc | 0.337671% | 25,104,003.1 | 655,457 NS |
|---|
| GERN | Geron Corp | 0.332969% | 24,754,402.57 | 16,613,693 NS |
|---|
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc | 0.321091% | 23,871,317.44 | 1,113,401 NS |
|---|
| PGEN | Precigen Inc | 0.312579% | 23,238,552.78 | 6,004,794 NS |
|---|
| VIR | Vir Biotechnology Inc | 0.30465% | 22,649,043.2 | 2,527,795 NS |
|---|
| KalVista Pharmaceuticals Inc | KalVista Pharmaceuticals Inc | 0.291873% | 21,699,173.76 | 1,077,952 NS |
|---|
| CTMX | CytomX Therapeutics Inc | 0.285184% | 21,201,869.2 | 4,511,036 NS |
|---|
| ANNX | Annexon Inc | 0.28491% | 21,181,458.72 | 3,823,368 NS |
|---|
| KURA | Kura Oncology Inc | 0.27593% | 20,513,859.9 | 2,523,230 NS |
|---|
| INBX | Inhibrx Biosciences Inc | 0.268199% | 19,939,140.63 | 296,581 NS |
|---|
| SLS | SELLAS Life Sciences Group Inc | 0.266837% | 19,837,896.3 | 4,689,810 NS |
|---|
| JANX | Janux Therapeutics Inc | 0.266343% | 19,801,106 | 1,424,540 NS |
|---|
| CMPX | Compass Therapeutics Inc | 0.262206% | 19,493,591.81 | 3,684,989 NS |
|---|
| SVRA | Savara Inc | 0.261084% | 19,410,136.2 | 3,554,970 NS |
|---|
| RIGL | Rigel Pharmaceuticals Inc | 0.257791% | 19,165,303.04 | 708,776 NS |
|---|
| SANA | Sana Biotechnology Inc | 0.25763% | 19,153,368 | 6,650,475 NS |
|---|
| CGEM | Cullinan Therapeutics Inc | 0.249904% | 18,579,020.81 | 1,307,461 NS |
|---|
| SPRY | ARS Pharmaceuticals Inc | 0.239082% | 17,774,453.18 | 2,213,506 NS |
|---|
| ZBIO | Zenas Biopharma Inc | 0.238313% | 17,717,285.25 | 906,255 NS |
|---|
| XNCR | Xencor Inc | 0.2307% | 17,151,285.78 | 1,422,163 NS |
|---|
| REPL | Replimune Group Inc | 0.226213% | 16,817,652.9 | 2,198,386 NS |
|---|
| SION | Sionna Therapeutics Inc | 0.224666% | 16,702,696.7 | 416,630 NS |
|---|
| VOR | Vor BioPharma Inc | 0.223742% | 16,634,016 | 932,400 NS |
|---|
| AVBP | ArriVent Biopharma Inc | 0.217556% | 16,174,100.16 | 701,088 NS |
|---|
| IRWD | Ironwood Pharmaceuticals Inc | 0.188814% | 14,037,276.24 | 3,999,224 NS |
|---|
| BCAX | Bicara Therapeutics Inc | 0.187716% | 13,955,679.27 | 701,643 NS |
|---|
| PRME | Prime Medicine Inc | 0.1863% | 13,850,375.64 | 3,979,993 NS |
|---|
| ALT | Altimmune Inc | 0.180343% | 13,407,520.28 | 4,353,091 NS |
|---|
| ABSI | Absci Corp | 0.179507% | 13,345,359 | 4,448,453 NS |
|---|
| EBS | Emergent BioSolutions Inc | 0.175605% | 13,055,277.5 | 1,572,925 NS |
|---|
| ALLO | Allogene Therapeutics Inc | 0.171079% | 12,718,758.64 | 5,212,606 NS |
|---|
| PURR | Hyperliquid Strategies Inc | 0.167831% | 12,477,300.24 | 2,451,336 NS |
|---|
| FDMT | 4D Molecular Therapeutics Inc | 0.165059% | 12,271,213.08 | 1,318,068 NS |
|---|
| VNDA | Vanda Pharmaceuticals Inc | 0.158382% | 11,774,854.21 | 1,704,031 NS |
|---|
| RGNX | REGENXBIO Inc | 0.153727% | 11,428,727.8 | 1,363,810 NS |
|---|
| LXEO | Lexeo Therapeutics Inc | 0.143816% | 10,691,938.18 | 1,862,707 NS |
|---|
| VSTM | Verastem Inc | 0.143613% | 10,676,844.7 | 2,014,499 NS |
|---|
| ABUS | Arbutus Biopharma Corp | 0.137284% | 10,206,292.5 | 2,268,065 NS |
|---|
| MYGN | Myriad Genetics Inc | 0.130762% | 9,721,444.5 | 2,160,321 NS |
|---|
| Prothena Corp PLC | Prothena Corp PLC | 0.128579% | 9,559,114.56 | 983,448 NS |
|---|
| OCGN | Ocugen Inc | 0.127155% | 9,453,302.39 | 5,222,819 NS |
|---|
| Rocket Pharmaceuticals Inc | Rocket Pharmaceuticals Inc | 0.125537% | 9,332,995.56 | 2,606,982 NS |
|---|
| MDXG | MiMedx Group Inc | 0.12128% | 9,016,507 | 2,282,660 NS |
|---|
| AKBA | Akebia Therapeutics Inc | 0.11291% | 8,394,205.83 | 6,038,997 NS |
|---|
| AVXL | Anavex Life Sciences Corp | 0.10959% | 8,147,420.81 | 2,653,883 NS |
|---|
| CONTRA METSERA INC | CONTRA METSERA INC | 0.100888% | 7,500,498.6 | 1,530,714 NS |
|---|
| IVVD | Invivyd Inc | 0.098878% | 7,351,012.5 | 5,654,625 NS |
|---|
| CATX | Perspective Therapeutics Inc | 0.09611% | 7,145,274.15 | 1,713,495 NS |
|---|
| State Street Global Advisors | State Street Global Advisors | 0.063222% | 4,700,194.36 | 4,700,194.36 NS |
|---|
| DMRA | Damora Therapeutics Inc | 0.032677% | 2,429,342.3 | 93,797 NS |
|---|
| CONTRA AKERO THERAPEUT | CONTRA AKERO THERAPEUT | 0.017783% | 1,322,083.75 | 2,033,975 NS |
|---|
| CONTRA INHIBRX INC | CONTRA INHIBRX INC | 0.014391% | 1,069,882.45 | 1,645,973 NS |
|---|
| CONTRA MIRATI THERAPEU | CONTRA MIRATI THERAPEU | 0.012895% | 958,686.4 | 1,369,552 NS |
|---|
| CONTRA VERVE THERAPEUT | CONTRA VERVE THERAPEUT | 0.007629% | 567,171.99 | 900,273 NS |
|---|
| CONTRA BLUEPRINT MEDIC | CONTRA BLUEPRINT MEDIC | 0.004681% | 347,975.74 | 756,469 NS |
|---|
| State Street Global Advisors | State Street Global Advisors | 0.000492% | 36,550.53 | 36,550.53 NS |
|---|
| OMNIAB INC | OMNIAB INC | 0% | 0 | 161,959 NS |
|---|
| OMNIAB INC | OMNIAB INC | 0% | 0 | 161,959 NS |
|---|